ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
EquitySector - Healthcare
42.83
0.04(0.09%)
NAV as on 10 Dec, 2025
CAGR
27.84%
- AUM (Crs.)6,437.36
- Expense Ratio1.03 %
- Sharpe Ratio / Category Average1.25 / 0.94
- Standard Deviation / Category Average15.70 / 16.00
- Beta / Category Average0.95 / 0.96
- Portfolio Turnover / Category Average82.51 / 56.14
- Top 5 Stocks Wt.44.04
- Top 10 Stocks Wt.62.15
- Top 3 Sectors Wt.97.10
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocks--
- Avg. Market Cap--
- Top 10 Stocks--
- Top 5 Stocks--
- Top 3 Sectors--
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistoryDharmesh Kakkad, Sharmila D’mello
- Launch Date12 Jul, 2018
- BenchmarkS&P BSE 500
Objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|